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Background: Cholera disease remains a global public health concern mostly in Lower and 
Middle income economies. Data on disease burden to the public health system for the pol-
icy decision makers to use are in adequate in Tanzania. This study aims to estimate the 
direct economic burden of Cholera disease in the Public health system. 
Methods: This is a retrospective study involving data of four years from 2015 to 2018 from 
the  Health management information system (HMIS) database from MOH Tanzania, Health 
facility registry, Ministry of Public service and good governance, MSD Tanzania, 
UNICEF, Previous publications and WHO. Data collected from the facility were entered 
to costing tool called “Choltool” to estimate the cost incurred by the facility to manage 
Cholera outbreak and cost to treat a single Cholera patient. Data from previous publication 
provided ranges of Cholera cases as minimum and maximum which were intertwined with 
data from MOH by using special equation to get average ranges of Cholera cases for each 
year. These cases were multiplied by cost to treat single patient to get sensitivity cost ranges 
in each year for the study years.  
Results:  In this study we found that, on average, the treatment cost of Cholera patient was 
estimated to be US$ 106.75. Furthermore, the average annual Cholera treatment ranged 
from US$ 3.24 million in 2015 to US$ 1.18 Million. In this study, we also found that facil-
ity support and supplies is the major driver for the treatment cost and constituted almost 




Conclusion: This study revealed the economic burden of cholera to public health care sys-
tem in Tanzania to be as high as US$ 106.75. Altogether, our findings have direct policy 
implications regarding investments in prevention of cholera. Future similar study economic 






Cholera as a diarrheal disease is still a global public health concern skewed mostly to Lower 
and Middle income economies. In the year 2017 alone, more than 1,227,391 Cholera cases 
and 5,654 Cholera deaths were reported to World Health Organization (WHO) by 71 coun-
tries, Africa attributed 14.7% of the cases and sub Saharan Africa accounted for the 49.1% 
of all Africa reported cases (World Health Organization, 2018). However, under reporting 
of Cholera cases and deaths to World Health Organization (WHO) by many countries in 
the world including Tanzania also remains as a big challenge to ascertain the magnitude of 
the problem. The reasons for under reporting in many countries including Tanzania are 
inadequacy of surveillance systems, weak diagnostic capacities and the fear of socio eco-
nomic and political consequences (World Health Organization, 2000). 
Recent study by Vital Mosagale et al in Asian countries reported that the estimated eco-
nomic burden of cholera illness in Asia is $41 million (95% CI: $26.5 million to $65.9 
million) and about $29 million (70.73%) is due to direct costs borne by the health system 
and individual family members (Vittal Mogasale, Vijayalaxmi V Mogasale, & Hsiao, 
2017). Another similar study conducted in Malawi by Ilboudo PG et al demonstrated a 
huge burden of Cholera cost in health facilities estimated to USD 59.7 per Cholera patient 
treatment (P. G. Ilboudo et al., 2017). 
Tanzania being among the Sub Saharan Africa, Cholera remains to be a problem of public 
health significance and therefore putting a society at high risk of Cholera outbreaks and 




studies conducted previously in Africa and Tanzania in particular on the economic burden 
of Cholera, however, the estimates of the burden of Cholera disease in the studies men-
tioned above were done by using modeling approaches. 
Cholera global burden study estimated that there are 2.86 million (uncertainty Range: 1.3M 
- 4.0M) Cholera cases and 95,000 deaths (Uncertainty Range: 21,000-143,000) annually in 
Cholera endemic countries, Tanzania included (Ali, R Nelson, Lopez, & Sack, 2015). Of 
1,227,391 of all WHO reported Cholera cases globally in 2017, 14.7% of the share of this 
burden of Cholera cases are reported from Africa in which case Sub Saharan Africa con-
tribute 49.1% of all cases, Tanzania being among Sub Saharan Africa has a share of 5.5% 
of all Cholera cases (World Health Organization, 2018).  Another study conducted by Mo-
hammed Ali et al showed that the estimated number of Cholera cases in Tanzania ranges 
from 80,952 to 84,550 in 2015 (Ali et al., 2015). 
In Tanzania about 48% (Veronicaa M. Mpazi & Mnyika, 2008) of all admissions in the 
country due to notifiable diseases among patients aged 5 years and above were due to chol-
era cases in the year 1997. About 57% of deaths due to notifiable diseases for 5 years old 
and above patients were cholera cases (Veronicaa M. Mpazi & Mnyika, 2008). For many 
years Tanzania has been a Cholera endemic country which reports cases to World Health 
Organization (WHO) annually (Poulos et al., 2012). Many factors such as shortage of clean 
water, improper waste disposal, poor food handling, processing, and preservation, poor 
housing, improper and lack of basic sanitation systems place people at a greater risk of 




those unable to access clean and safe water, poor families and mostly the rural and urban 
families in suburbs lacking basic sanitation facilities (Veronicaa M. Mpazi & Mnyika, 
2008).  
Geographical, socio-economic and socio cultural backgrounds of people in the affected 
area which influence practices may also contribute to spread of cholera. These include low 
educational level, unhygienic food handling practices, poor use of latrines, poor disposal 
of excreta and proximity to surface water. This is because the bacteria (Vibrio cholerae) 
that cause cholera are known to be normal inhabitants of surface water (Veronicaa M. 
Mpazi & Mnyika, 2008). 
In Tanzania, cholera outbreaks had been occurring every year since 1977, when the first 
person believed to have been affected by the disease was first reported (Acosta CJ et al., 
2001). Tanzania was found to have the highest number of cases in Africa in 1997 (40,249) 
and 1998 (43,000) compared to Guinea Bissau (20,555), Kenya (17,200), Chad (8,801) and 
Mozambique (8,708) in 1997 and Kenya (18,000), Uganda (18,000) and Somalia (14,708) 
in 1998 (10). Tanzania had one of the highest case fatality rates in East Africa with 2,268 
deaths out of 40,226 cases (Crescent, 2007). 
Tanzania has been embarking much efforts in the investment of curative health services in 
the public health Care system and preventive control strategies which are key to controlling 
infectious diseases had been allocated very little share in the nation health budget 
(UNICEF, 2018) (Tarimo, 2018) and therefore making fight against Cholera disease diffi-




To have a full insight of the broader economic impacts of Cholera on the Public health care 
system, the costs of illness incurred by the health care facilities have to be assessed and 
aggregated country wide. The information on the economic burden of Cholera which will 
be obtained from this study is of paramount importance for the government in conducting 
economic evaluations and making decision on Cholera control strategies such as clean wa-
ter availability and access, basic sanitation and Hygiene (WASH) Strategy. The implemen-
tation of WASH strategy by the government will offset the cost incurred for treatment of 
Cholera cases, prevent morbidity and mortalities caused by the disease.   
Moreover, information on economic burden of Cholera will serve as advocacy tools to pol-
icy decision makers in demonstrating how important WASH strategy is more cost effective 
preventive measure compared to curative strategies. The implementation of WASH strat-
egy and the use of Cholera vaccine in high prone Cholera areas (Cholera hotspots) will 
pave the way to eradication of Cholera and other diarrheal diseases in the country and sub-
sequent create better environment for the development of the country.  
 
 
Goal and Objectives of the study 
Goal 
This study aimed to estimate the direct economic burden of Cholera to the public health 
care system for the purpose of creating awareness to policy makers for possible subsequent 






This study will answer the following objectives: 
 To estimate direct economic costs incurred by public health system to treat a Cholera 
patient. 
 To estimate direct economic costs incurred by public health facility to manage Cholera 
outbreak. 
 To estimate direct economic costs incurred by the country’s public health care system 











Description of the study setting and Cholera Outbreak 
 
Cholera outbreak occurred in 2018 in Kimamba ward which comprises 8 villages and it 
has an area of 29 Km2 and a population of 12,046 with 5,835 Male, 6,211 Women, and 
1,663 Children under 5 years, 3,796 Children aged 5 to 14 years and 6,587 aged above 15 
years old. This is a rural area and has one health centre (Kimamba health centre) which is 
serves the whole population and basic primary health care services are delivered. This fa-
cility had a total of 42 health personnel which were involved in the management of the 
outbreak.  Community obtain water supply for domestic consumption through mostly tem-
porary underground shallow wells and majority of household neither boil nor treat drinking 
water. Access to basic water in Kimamba ward is around 37% according to information 
from the District medical officer office. Most of households used pit latrine as means of 
fecal disposal and about 23% of the households have pit latrines with slab floor (Minitry 
of Health and Soical Welfare, 2011). 
The outbreak in 2018 in Kimamba ward occurred during rainy season (January to April) as 
the result of resumption of temporary wells which formed due to rain water collection. This 
outbreak was reported by Kimamba health centre which was the used as the Cholera treat-
ment centre to manage the outbreak. The outbreak affected 72 people (43 Male and 29 





The data on the number of cases of Cholera reported for four years to the Ministry of 
Health- Tanzania in 2015, 2016, 2017 and 2018 were requested and retrieved from the 
Ministry of Health’s Management information System (HMIS) database (CHILDREN, 
2019). In Tanzania, infectious diseases including Cholera are reported under Integrated 
Disease Surveillance and Response (IDSR) as weekly epidemiological records and annu-
ally aggregated to obtain a nation annual summary cholera report. Furthermore, aggregated 
annual cholera data from the Ministry of Health were referenced to WHO cholera report 
for 2018 (World Health Organization, 2018) to ascertain its correctness. To narrow down 
to get the cost incurred by public health facility, data for Cholera cases were collected from 
one of the District (Kilosa District) in Tanzania where outbreak occurred, these data were 
retrieved from 2018 Kimamba health center registry and were compared to the District 
Health information system 2 (DHIS2) (CHILDREN, 2019). Prices for drugs and medical 
supplies will be obtained from Medical store department (MSD) catalogue for 2018 
(Tanzania, 2018) and for items which are not available in Tanzania MSD price catalogue 
will be obtained from UNICEF supply catalogue (UNICEF, 2019). The prices for building 
equipment and structural materials were requested from the district Medical Officer to get 
the local prices for materials used for setting up tents for Cholera treatment center. To avoid 
underestimation and overestimation of Cholera cases and therefore the cost incurred in 
treatment, we used conservative sensitivity ranges of Cholera cases reported in other study 




of service delivery such as Manpower (Salaries and allowances) were requested and ob-
tained from Tanzanian Ministry of President’s Office-Public servant Management where 
circulars used for manpower salaries and allowances were given. World Health Organiza-
tion (WHO) treatment guideline (World Health Organization, 2015) will be used to provide 
standard treatment for mild/moderate and severe cholera. Currency exchange rate used was 
collected from Google currency converter (Converter, 2019). The table 1 below summa-
rizes expenditure variables of the study and sources of data for health system. 




Description of costs Source 
Staff in-
centives 
Salaries, Perdiems, Standard meal allow-
ance, 
Extra duty allowances, Transport fares 
 President's Office - Pub-
lic Service Management 
and Good Governance. 
 
(Circular Ref No 
AC.128/260/01 Revision of 
Salaries in the Civil Service 






Zinc sulphate, Sodium Lactate infusion, 
ORS, Infusion giving set, Needle, Scalp 
vein, 
Tourniquet, latex, Tube feeding, Feces Col-
lection container, Erythromycin powder, 
Doxycycline caps, Container Sample, 
Ciprofloxacin caps 500 mg, Cannula 
(16G,18G,22G) Razor, Safety, single use 





Tanzania MSD price cata-
logue 2018-2019 final. 











Water purification tablets, 
Safety boxes for used syringes, Povidone 
soln 10% BOT/200ml, Polyvidone Iodine 
10% BOT/500ml, Medical tape 
Gloves, Mop with hand, Drum for Chlorine 
soln, Chlorine 40 mg for 10L water, IEC ma-
terial (Flipchart), Chlorine test tables DPD3, 
Bag, biohazard, Chlorine test tablets DPD1 
UNICEF Supply Catalog 
(accessed July 2019) 
    
  
Cup plastic 500ml, Bucket, HDPE 20L with 
Lid Bucket, HDPE 14L with lid 
Bucket, plastic 14L with clip cover, Water 
tank kit, OXFAM type 5000L, Note book, 
Rake, Spade and Pick Axe 
Dr Halima Mohamed, Ki-
losa district Medical Of-
ficer.  
 
Cotton Wool, Gauze, Body bag (PIC) 
Boots, rubber (PVC), reusable (size 42, 43, 
44),Basin for water collection 
Bucket, HDPE 5L, Apron, disp(PAC), Plas-
tic dustbin with cover, Stand for hand wash-
ing, Chlorine ½ container, Blanket 
Tanzania MSD price cata-
logue 2018-2019 final. 




Fuel for ambulance 
Burial Costs 
Dr Halima Mohamed, Ki-





Tents (small, medium and Large), Pit latrine 
Washing rooms 
Dr Halima Mohamed, Ki-
losa district Medical Of-
ficer.    
 
Glucometer, Stethoscope, Weigh Scale 
(Child and Adult) and Sphygmomanometer 
(adult and Child). 
Tanzania MSD price cata-
logue 2018-2019 final. 
    
    
   
  
Plastic Mat 
UNICEF Supply Catalog 
(accessed July 2019) 







Because of the cholera endemicity in the country, four years under study will be from 2015 
to 2018. The selection of more recent years based on the fact that the study result will 
provide a close to reality picture of estimation economic burden of Cholera in the public 
health system. 
Data Management and analysis tool 
The study used a Cholera tool software called “Choltool” which is a standardized Microsoft 
excel-based for cholera cost analysis. This is Cholera cost analysis calculator developed by 
International Vaccine institute (IVI), WHO and DOVE (International Vaccine Institute, 
2018). This tool however uses health system economic perspective of treatment costing 
where individual household direct and indirect costs are not included. All costs for medical 
supplies, medicine and manpower capital will be entered in the “Choltool” for analysis.  
This tool has costs divided into two categories financial and economic costs. Financial costs 
are the explicit costs which are typically reported in standard accounting reports and are 
the direct expenditures which outlays for the previous year same outbreak management 
while economic costs are financial costs (explicit costs) plus monetized valuation of all 
inputs needed for the treatment of Cholera patients including valuation of time, supplies, 
equipment and annualization of costs that adjusts for a discount rate (Logan Brenzel, 2013) 




This Choltool is in a series of worksheets in a single workbook and it has interlinked mod-
ules which contain input, output, dashboard, variable selection, assumption and formulas 
to produce outputs. 
Variables used for Cost estimation 
We used a special costing tool called “Choltool” to analyze data to get the average cost 
estimation for the treatment of Cholera patient.  Following below are the variables which 
were selected in this study, 
Direct Costs for drugs and medical supplies 
This represents the sum total of all costs incurred by the public health care system in for 
the use of drugs and medical supplies in treating Cholera patients. For drugs, these include 
those which are used to treat all Choler and all forms of diarrhea which are daily dosage of 
ORS, antibiotics, intravenous fluids and Zinc for Children. For patients with severe Chol-
era, the product of dosage of Doxycycline and Ringer Lactate (Hartmann’s solution), num-
ber of times a dosage of Tetracycline is taken per day, price per unit of Tetracycline and 
the number of patients with severe Cholera Medical supplies include gloves, cannula and 
all other non-medicine items. This costs are reflected as economic costs. Number of doses 
and the medical supplies used treating each patient are multiplied with the price of each 
item to get the cost incurred for this variable. Table 2 depicts WHO cholera standard treat-





Table 2” Standard treatment regimens for Cholera cases. 



























qid x 3/7 





Solution (IV) in 
Liters (L) 
1L OD x 
3/7 
1L OD x 
3/7 








Qid- four times per day, OD- Once per day, 3/7- three days of a week. 
Source: Current WHO 2011 Guideline for Cholera treatment 
  
Personnel costs for Salary Payment, travel and allowances 
This includes costs for public health facility for personnel monthly salaries and allowances 
for extra duty and transport for personnel. The salary of each personnel cadre was multi-
plied by the number of health personnel in the facility to get the total economic cost in-
curred in a Cholera treatment center.  Because Cholera outbreak is a Public health emer-
gency and mitigation for response is implemented by government, health personnel work 
in extra hours and they are paid extra duties in which standardized allowance is computed 
by the “Choltool” to yield costs incurred and because these costs are paid due extra duty 




Facility treatment support supplies 
This variable includes the costs incurred by the public health care system for items used to 
enhance infection prevention and control such as Chlorine for cleaning, biohazards safety 
boxes and material for health communication and education to the community such as IEC 
materials, stationaries etc. 
Other Costs 
These include costs incurred by the public health care system for burial of deceased cholera 
patient which for the purpose of controlling further spread of Cholera the government took 
the responsibilities of burial of deceased ones with collaboration with the families of the 
deceased. Other costs in this category is the fuel for ambulance services which was used 
during emergency needs. 
Equipment 
This variable includes the costs of all medical equipment which are used in health facility 
for treatment, examples includes hospital beds, glucometer, basins, BP machine etc. 
Structures 
This category of variable include any physical construction done during Cholera outbreak 





Average Cost estimation Modeling 
A. Real public health facility cost estimation 
We used the costing tool “Choltool” as a software to manage our data. “Choltool” devel-
oped by International vaccine institute, WHO and DOVE (Tembo et al., 2019). All data 
collected from the public health facility were entered into the “Choltool”, verified and com-
puted automatically to yield output for each variable. The total cost incurred by one public 
health facility which managed the outbreak of Cholera disease during the outbreak was 
found. Furthermore, the “Choltool” calculated the average cost incurred to treat one Chol-
era patient.  
B. Cost estimation for the whole country 
To extrapolate and obtain the total average cost estimation incurred by the whole country 
we used three sources of data for comparison and applied some modeling to get data for 
four years from 2015 to 2018. The data for Cholera cases for the whole country were un-
certain because data reported in the Ministry of health Tanzania had minor discrepancies 
with those reported in WHO (Table 5). The much concern that we noted is about under 
reporting of cases after comparing data from the Ministry of Health Tanzania and data from 
a published study on the updated Cholera cases by Mohammad Ali et al which showed a 
myriad differences. Cholera Cases Sensitivity ranges were estimated based on Population 
at risk and incidence rate from a study conducted by Mohammad Ali et al (Ali et al., 2015). 




system and because data for Cholera cases are uncertain, we linked Cholera data cases from 
the Ministry of Health and retrieved published updated Cholera cases from study by Mo-
hammad Al et al to establish a range of Cholera cases as minimum and maximum cases. 
To get this Cholera case range we used Conservative sensitivity ranges published by Mo-
hammad Ali et al which was a one year study as a baseline and extrapolated for the four 
years from 2015 to 2018. According to Mohammad Ali et al published Cholera data, Con-
servative sensitivity Range one (S1) was estimated based on population at risk based on 
percentage without sustainable access to improved water and conservative sensitivity two 
(S2) cases was estimated based on the 50% of the  incidence rate estimate. 
However, since Cholera sensitivity cases retrieved from the published updated Cholera 
cases study by Mohammad Ali et al. were for one year, therefore to estimate the sensitivity 
ranges for our study years we used Sensitivity factor ratios (SFRs) for conservative Sensi-
tivity one (S1) and Sensitivity two (S2) to get the Sensitivity case ranges. Sensitivity factor 
ratio (SFR) is defined as the constant obtained by taking the ratio of sensitivity one and 
two. Sensitivity ratio factor one (SRF1) is the product of Cholera sensitivity one (S1) cases 
retrieved from the study divide by total of Sensitivity one (S1) and sensitivity two (S2). 
Similarly, Sensitivity ratio factor two (SRF2) is the product of Cholera Sensitivity two (S2) 

















SFR1 is Sensitivity factor Ratio one 
SFR2 is Sensitivity factor Ratio two 
S1 is maximum conservative Sensitivity one from a previous study publication. 
S2 is Minimum conservative Sensitivity two from a previous study publication.               
These sensitivity factor ratios (SFRs) as constants were then used for calculation of each 
year’s estimated number of Cholera cases from 2015 to 2018. To further minimize the 
effect of under reporting or over reporting of Cholera cases, we used the number of Cholera 
cases reported in the Ministry of Health as integral part of the equation used to estimate 
Cholera cases for each respective study year. The ratio of Cholera cases for each study year 
was multiplied to the total conservative Sensitivity ranges one and two (S1 and S2). To get 
estimated Cholera cases for each respective year then Sensitivity  factor ratio one (SFR1) 




cases, Similarly, Sensitivity factor ratio two (SFR2) was multiplied by reported Cholera 
cases to MOH to get Minimum estimated Cholera in each respective year.  The integral 
equation for estimation of Cholera cases is as follows, 
𝑋𝑖 =   
𝑛𝑖
𝑁
  𝑆1 + 𝑠2  𝑆𝐹𝑅 
Where, 
Xi is the estimated Cholera Cases in a respective year. 
ni is the number of Cholera cases reported to MOH in a particular year. 
N is total number of reported cases for four study years. 
SFR is the Sensitivity Factor ratio, Constant. 
S1 is maximum Conservative Sensitivity range 









Table 3: Estimated Sensitivity Ranges for Cholera cases from 2015 to 2018. 
Year 






2015 12,118 31,665 29,129 
2016 11,360 29,684 27,275 
2017 4,636 12,105 11,131 
2018 4,414 11,525 10,598 




Unit of costs 
We used an estimation in United States Dollars (US$) 2018) and Tanzanian Shilling 
(TZS).The costs to be reported are converted to 2018 US$ to reflect the actual costs in-
curred. 
Ethics statement 
This study followed protocol set by Yonsei University Postgraduate school of Public 
Health Research Ethics Committee. Permission to get data from the Ministry of Health 




of Health Tanzania. Fidelity form for ethical conduct from Yonsei Postgraduate School of 















Average Cholera treatment cost for one sampled public health facility. 
Table 4 shows the average cost per health facility for treating a cholera patient, the distri-
bution of costs as operational and capital costs. On average, the treatment cost incurred per 
public health facility was US$ 7,686.24 which is sum total of financial and economic costs 
of both operational and capital costs. Operational costs accounts for almost 92.06% (US$ 
7,075.64) of all costs incurred by the health facility and the remaining (7.94%) costs are 
due to capital costs. Moreover, we found that facility support supplies account for almost 
34.1% (US$ 2,615.58) of the cost incurred by the health facility, other costs in the health 
facility came as the second most important driver accounting for 21.8% (US$ 1,676.10) of 
incurred costs, travel and allowances by 20.9% (US$ 1,602.08). We are not surprised that  
drugs and medical supplies were the smallest driver, accounting for about 10.5% (US$ 
807.78) incurred by the health facility for treating the disease, this is because treatment in 
all cases is mostly rehydration and single antibiotic and also shorter hospital stay (3-4 days). 
Other drivers for the treatment costs are structures which account for 7.6% (US$ 580.46) 
and personnel which account for 4.9% (US$ 374.10). This study also found that, for the 
costs incurred by the health facility in the treatment of Cholera patient, economic costs 






Table 4: Cholera treatment cost per public health facility. 






Salaries 0.00 374.10 
Travel & Allowances 801.04 801.04 
Drugs and Medical Supplies 403.89 403.89 
Facility Support Supplies 1307.79 1307.79 
Other  Costs 838.05 838.05 
Total Costs (Operational) 3350.77 3724.87 
Capital Costs (Annual-
ized) (only in months 
when facility is in opera-
tion) 
Equipment 10.05 10.81 
Structures 290.23 299.49 
Total Costs (Capital) 300.29 310.31 
Average Cost per Facility 3651.06 4035.18 
 
 
Estimated Cholera treatment cost incurred per single Cholera patient 
Table 5 depicts the treatment costs incurred per patient, recurring and capital costs. In this 
study we found that the average cost incurred in the treatment per patient is US$ 106.75 
which is the sum total of financial and economic costs of both operational and capital costs. 
Operational costs account for 92.1 % (US$ 98.27) of all cost whereby capital costs contrib-
ute for 7.9 % (US$ 8.48). Moreover, we found that economic costs account for almost 52.2 
% (US$ 55.75) of the treatment costs while financial costs account for 47.8% (US$ 50.41).  
In average costs per patient, we found that facility support supplies accounted for 34.0% 




23.26) and then travel & allowances by 20.9% (US$ 22.26). Personnel accounts only for 
4.9% (US$ 5.20) of the total operational cost per patient. In the capital costs, Structures 
contributed almost 7.7 % (US$ 8.19) of the cost incurred per patient. 
Table 5:  Average Cost per treatment of one Cholera patient. 






Salaries 0.00 5.20 
Travel & Allowances 11.13 11.13 
Drugs and Medical Supplies 5.61 5.61 
Facility Support Supplies 18.16 18.16 
Other  Costs 11.64 11.64 
Total Costs (Operational) 46.54 51.73 
Capital Costs (Annual-
ized) 
Equipment 0.14 0.15 
Structures 4.03 4.16 
Total Costs (Capital) 4.17 4.31 
 
Estimated Cholera treatment cost annually for four years incurred by 
Public health care system 
Table 6 depicts the estimated annual Cholera treatment costs incurred by the public health 
care system from 2015 to 2018. Our study found that annually, public health care system 
incurred an estimated cost ranges from US$ 3,244,879.75 (Sensitivity Cost range: US$ 




2,911,606.25 - US$ 3,168,767.00), US$ 1,240,221.50 (Sensitivity Cost range: US$ 
1,188,234.25- US$ 1,292,208.75) and US$ 1,180,815.12 (Sensitivity Cost range: US$ 
1,131,336.50- US$ 1,230,293.75) in 2015, 2016, 2017 and 2018 respectively. Moreover, 
we found that the estimated total Cholera cases treatment costs incurred by the public health 
care for the period of four years from 2015 to 2018 is amounting US$ 8,702,099.87 (Sen-
sitivity cost range: US$ 8,337,175.00 to US$ 9,067,024.75). 































2015 12,118 11,563 31,665 3,380,238.75 29,129 3,109,520.75 3,244,879.75 
2016 11,360 11,360 29,684 3,168,767.00 27,275 2,911,606.25 3,040,186.62 
2017 4,636 4,895 12,105 1,292,208.75 11,131 1,188,234.25 1,240,221.50 
2018 4,414 4,389 11,525 1,230,293.75 10,598 1,131,336.50 1,180,815.12 
Total 32,528 32,207 84,937 9,067,024.75 78,100 8,337,175.00 8,702,099.87 
 
Figure 1 shows the trend of Cholera treatment costs incurred by the Public health care 
system for four years. The study found that Cholera treatment costs incurred by Public 
health care system for 2016 and 2017 were slightly similar at an average cost of US$ 




2017 and 2018 respectively. Moreover, Cholera treatment costs for the past latest years that 
is 2017 and 2018 had not changed much as trend is fairly the same. 
 
Figure 1: Trend of Cholera treatment costs to public health care system for four years. 
 
Figure 2 depicts average estimated costs incurred in each year in each variable cost.  The 
figure shows that facility support supplies cost significantly than all other item costs in each 
year US$ 1,104,019, US$ 1,034,375, US$ 421,965 and US$ 401,754 for 2015, 2016, 2017 
and 2018 respectively. This is followed by other direct costs, travel and allowances, drugs 

















Figure 2: Trend of Cholera treatment costs by cost variable for four years. 
Estimated cost according to disease severity and age group of patient 
Figure 3 shows disaggregated average treatment cost annually for four (4) years per dis-
ease severity per age group. Figures shows that group aged 5-14 years with Mild- moderate 
dehydration accounted more for the annual treatment cost incurred each year which was 
US$ 674,927.9 for 2015 and US$ 245578.4 for 2018. This was followed by group aged 
15+ years with severe dehydration as US$ 629504.8 for 2015 and US$ 229085.5 in 2018. 
However, group aged under 5 years with severe dehydration extended stay showed to cost 












Personnel Drugs and medical supplies




















U5mild-mode dehydration U5 Severe dehydration
U5 severe dehydration extended stay 5-14yrs Mild-moderate dehydration
5-14 severe dehydration 5-14 severe dehydration extended stay
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This study estimated the costs of treating Cholera patient incurred by the public health 
system in Tanzania. This study, we found that on average, public health care system in-
curred US$ 106.75 in the treatment of one patient of Cholera for one Cholera episode. 
About 32,528 cases of Cholera were reported to the Ministry of Health Tanzania and WHO 
for four (4) years from 215 to 2018 showed minor discrepancies but with the estimated 
conservative sensitivities reported from some reputable study by Mohamed Ali et al. Chol-
era Sensitivity case range of 78,100 to 84,937 estimated conservative cases of cholera for 
Tanzania for four years from 2015 to 2018 resulted in a total economic loss of US$ 
8,702,099.87 (Sensitivity cost range US$ 8,337,175 – US$ 9,067,024.75 ). Cholera treat-
ment cost incurred by the public health system revealed to account for approximated at 
US$ 3.24 million, US$ 3.04 million, US$ 1.24 million and US$ 1.18 million for 2015, 
2016, 2017 and 2018 respectively. In addition, our study found that Cholera treatment cost 
incurred by our public health facility that we used as focal study site was about US$ 
7,676.22. This study found that the cost for Cholera treatment decreased progressively from 
2015 to 2018 due to the fact that the number of cases reported decreased. Moreover, our 
study found that the main driver of treatment costs of cholera in this study is facility support 
supplies which accounted for 34.0% (US$ 36.32) of the all treatment cost incurred by the 
public health care system, this was followed by other  costs by 21.8% (US$ 1,676.10)  and 




medical supplies were the smallest driver, accounting for less than 10.5% (US$ 807.78) 
incurred by the health facility for treating the disease because treatment in all cases is 
mostly rehydration and single antibiotic and also shorter hospital stay (3-4 days). 
The finding from our study that Cholera treatment cost incurred by public health care sys-
tem per patient to be as high as US$ 106.75 is contrary to other studies results which were 
reported previously including US$ 61 in Zanzibar, Tanzania, in 2012 (Schaetti et al., 2012) 
and between US$ 17.6–28.4 in Matlab (Bangladesh), Kolkata (India), Beira in 
(Mozambique), and North Jakarta (Indonesia) (Sarker et al., 2013).   Approximately 
34.21% of all treatment costs were due to facility support and supplies and in our study we 
found facility support and supplies to be the driver for the treatment costs. However, we 
were not surprised as one could think drugs and medical supplies could be a driver factor 
for treatment cost but instead we found not even among top four of the leading drivers of 
Cholera treatment drivers. This is because Cholera disease is principally treated by Oral 
rehydration fluids and a single dose of antibiotic and duration of hospitalization is as short 
as 3 to 4 days only.  
This study has numerous assumptions and therefore the accuracy of the Cholera treatment 
estimates based on the plausibility of the assumptions that WHO Cholera treatment guide-
line was used consistently during management of Cholera cases.  Therefore, this study re-
sults interpretation should be tempered with the limitations highlighted beneath. We should 
emphasize that the purpose of this study on the estimate of Cholera treatment burden to the 




of the study results but rather this stool will be a tool to raise awareness among policy-
makers and the public in general about the negative economic impact of cholera. Moreover, 
it is worth mentioning that many other diarrheal, respiratory, and vector borne diseases 


















This study has a myriad number of limitations. First, our study did not assess direct costs 
incurred by the household such as providing food to the patient, transport cost for visiting 
patient hospitalized, costs of hotels for relatives/caregiver. This costs may have contributed 
to underestimating the actual cost of treating patient with Cholera disease in this study. 
Second, because cholera outbreaks are largely unpredictable, health care personnel are not 
hired specifically to deal with this illness but rather are pulled from other duties and from 
other facilities. This, in turn, has a cascading effect on the health system especially on 
delivery of health services to other non-Cholera illnesses, this effect was not explored as it 
was not in the scope of this study but could have also led to underestimation of treatment 
cost. Third, this study did not estimate the indirect costs associated with Cholera outbreak, 
these indirect costs include costs associated with loss of tourism due to fear of the cholera 
outbreak, closure of businesses and economic opportunities for affected communities, clo-
sure of schools and the days lost thereafter. Fourth, this study did not account for mortality 
cost associated with DALYs calculations and therefore this could have led to underestima-
tion of impact of Cholera to the public health system. Fifth, data of our study were collected 
retrospectively for four years, data collected were however showing significant discrepan-
cies between those from Ministry of Health Tanzania, those reported in WHO and the es-
timated cholera cases from study done by Mohamed Ali et al. This myriad differences in 
these sources was the reason to select Sensitivity ranges established by study by Mohamed 




our study did not include the estimation of values of preexisting health facility building 
such as wards which were assigned for management of Cholera cases during the outbreak. 
This exclusion could have dramatically increased the cost incurred in the management of 
Cholera cases than what have been found in our study. The study results revealed to be 
contrary to other studies reported previously and the partial reason for this might be due to 
















The fact that our study has vast limitations as pointed out above, this study carries a number 
of strengths. Most of the literature review we found on economic impact of Cholera come 
from Asian countries and only very few published literatures are from Africa and only one 
study was conducted in Zanzibar archipelago, Tanzania. Cholera disease is endemic in 
Tanzania and in most Sub Saharan Africa, hence there is a need for more studies of this 
nature to be conducted in Sub Saharan Africa and Tanzania in particular to raise awareness 
to policy-makers and public in general about the impact of the disease to the economy. 
The high estimated cost of US$ 106.75 for treatment of a single Cholera patient revealed 
from this study point out clearly the need for further extensive research in Tanzania to 
ascertain the burden of Cholera that is inflicting in the country’s economy. This study there-
fore may serve as a catalyst for setting up comprehensive study on the burden of Cholera 
outbreaks on the general economy of the country and subsequent shift of the paradigm of 










Our findings revealed that Cholera impact in Tanzania stands high at about US$ 106.75 for 
treatment of a single Cholera patient when comparing with other studies which found to be 
US$ 17.6-28.4 in Matlab (Bangladesh), Kolkata (India), Beira (Mozambique) and  US$ 61 
in Zanzibar. The treatment cost for the whole Country revealed to decrease on annual basis 
and ranged around US$ 3.24 million to US$ 1.18 million from 2015 to 2018 respectively. 
This study is important for policy and Pubic health decision-makers in Tanzania as it cre-
ates awareness about the alarming Cholera impact on the Country’s economy. This study 
entails the urgent need for improved Cholera surveillance, quality data collection and re-
porting and the country need for paradigm shift in combating Cholera by investing signif-
icantly on basic sanitation and hygiene, improve access to clean and safe water and the use 
of oral Cholera vaccine in cholera hot spots to eliminate the disease. The study also offers 
a light about the need for further future overarching research in the country to ascertain the 
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